Anjan K. Pradhan

1.3k total citations
33 papers, 854 citations indexed

About

Anjan K. Pradhan is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Anjan K. Pradhan has authored 33 papers receiving a total of 854 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 12 papers in Oncology and 10 papers in Genetics. Recurrent topics in Anjan K. Pradhan's work include Virus-based gene therapy research (8 papers), Hippo pathway signaling and YAP/TAZ (8 papers) and Axon Guidance and Neuronal Signaling (8 papers). Anjan K. Pradhan is often cited by papers focused on Virus-based gene therapy research (8 papers), Hippo pathway signaling and YAP/TAZ (8 papers) and Axon Guidance and Neuronal Signaling (8 papers). Anjan K. Pradhan collaborates with scholars based in United States, India and Belgium. Anjan K. Pradhan's co-authors include Swadesh K. Das, Paul B. Fisher, Luni Emdad, Devanand Sarkar, Praveen Bhoopathi, Sarmistha Talukdar, Xue‐Ning Shen, Xiang‐Yang Wang, Jolene J. Windle and Webster K. Cavenee and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Cancer Research and Oncogene.

In The Last Decade

Anjan K. Pradhan

33 papers receiving 846 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anjan K. Pradhan United States 20 425 239 206 178 135 33 854
Masayo Hosokawa Japan 15 471 1.1× 252 1.1× 133 0.6× 151 0.8× 96 0.7× 21 964
Hua Wu China 13 526 1.2× 154 0.6× 192 0.9× 205 1.2× 88 0.7× 21 838
Lucia Cappabianca Italy 19 570 1.3× 185 0.8× 282 1.4× 114 0.6× 91 0.7× 45 944
Taiji Yamazoe Japan 13 546 1.3× 437 1.8× 231 1.1× 125 0.7× 115 0.9× 26 1.0k
Chan Choi South Korea 19 633 1.5× 265 1.1× 227 1.1× 73 0.4× 159 1.2× 32 1.1k
Charlotte E. Edling United Kingdom 14 606 1.4× 273 1.1× 124 0.6× 136 0.8× 81 0.6× 32 1.0k
Chun-Hau Chen United States 13 833 2.0× 354 1.5× 127 0.6× 240 1.3× 132 1.0× 13 1.1k
Jin Cen China 17 748 1.8× 207 0.9× 191 0.9× 84 0.5× 83 0.6× 24 1.3k
Claudio Raimondi United Kingdom 18 841 2.0× 233 1.0× 234 1.1× 106 0.6× 207 1.5× 27 1.2k
Sean Garrison United States 10 595 1.4× 354 1.5× 142 0.7× 135 0.8× 101 0.7× 13 970

Countries citing papers authored by Anjan K. Pradhan

Since Specialization
Citations

This map shows the geographic impact of Anjan K. Pradhan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anjan K. Pradhan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anjan K. Pradhan more than expected).

Fields of papers citing papers by Anjan K. Pradhan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anjan K. Pradhan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anjan K. Pradhan. The network helps show where Anjan K. Pradhan may publish in the future.

Co-authorship network of co-authors of Anjan K. Pradhan

This figure shows the co-authorship network connecting the top 25 collaborators of Anjan K. Pradhan. A scholar is included among the top collaborators of Anjan K. Pradhan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anjan K. Pradhan. Anjan K. Pradhan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Baisakh, Niranjan, et al.. (2023). Comprehensive meta-analysis of QTL and gene expression studies identify candidate genes associated with Aspergillus flavus resistance in maize. Frontiers in Plant Science. 14. 1214907–1214907. 8 indexed citations
2.
Das, Subhayan, Moumita Kundu, Aditya Parekh, et al.. (2023). A novel computational predictive biological approach distinguishes Integrin β1 as a salient biomarker for breast cancer chemoresistance. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1869(6). 166702–166702. 6 indexed citations
3.
Pradhan, Anjan K., Praveen Bhoopathi, Santanu Maji, et al.. (2022). Enhanced Cancer Therapy Using an Engineered Designer Cytokine Alone and in Combination With an Immune Checkpoint Inhibitor. Frontiers in Oncology. 12. 812560–812560. 5 indexed citations
4.
Liu, Zheng, Chunqing Guo, Swadesh K. Das, et al.. (2021). Engineering T Cells to Express Tumoricidal MDA-7/IL24 Enhances Cancer Immunotherapy. Cancer Research. 81(9). 2429–2441. 12 indexed citations
5.
Bhoopathi, Praveen, Anjan K. Pradhan, Santanu Maji, et al.. (2021). Theranostic Tripartite Cancer Terminator Virus for Cancer Therapy and Imaging. Cancers. 13(4). 857–857. 6 indexed citations
6.
Pradhan, Anjan K., Amit Kumar, Sarmistha Talukdar, et al.. (2021). Insights into the Mechanisms of Action of MDA-7/IL-24: A Ubiquitous Cancer-Suppressing Protein. International Journal of Molecular Sciences. 23(1). 72–72. 11 indexed citations
7.
Das, Swadesh K., Timothy P. Kegelman, Anjan K. Pradhan, et al.. (2019). Suppression of Prostate Cancer Pathogenesis Using an MDA-9/Syntenin (SDCBP) PDZ1 Small-Molecule Inhibitor. Molecular Cancer Therapeutics. 18(11). 1997–2007. 22 indexed citations
8.
Pradhan, Anjan K., Praveen Bhoopathi, Sarmistha Talukdar, et al.. (2019). MDA-7/IL-24 regulates the miRNA processing enzyme DICER through downregulation of MITF. Proceedings of the National Academy of Sciences. 116(12). 5687–5692. 23 indexed citations
9.
10.
Emdad, Luni, Praveen Bhoopathi, Sarmistha Talukdar, et al.. (2019). Recent insights into apoptosis and toxic autophagy: The roles of MDA-7/IL-24, a multidimensional anti-cancer therapeutic. Seminars in Cancer Biology. 66. 140–154. 71 indexed citations
11.
Das, Swadesh K., Anjan K. Pradhan, Praveen Bhoopathi, et al.. (2018). The MDA-9/Syntenin/IGF1R/STAT3 Axis Directs Prostate Cancer Invasion. Cancer Research. 78(11). 2852–2863. 42 indexed citations
12.
Pradhan, Anjan K., Praveen Bhoopathi, Sarmistha Talukdar, et al.. (2018). Recombinant MDA-7/IL24 Suppresses Prostate Cancer Bone Metastasis through Downregulation of the Akt/Mcl-1 Pathway. Molecular Cancer Therapeutics. 17(9). 1951–1960. 21 indexed citations
13.
Talukdar, Sarmistha, Anjan K. Pradhan, Praveen Bhoopathi, et al.. (2018). MDA-9/Syntenin regulates protective autophagy in anoikis-resistant glioma stem cells. Proceedings of the National Academy of Sciences. 115(22). 5768–5773. 97 indexed citations
14.
Pradhan, Anjan K., Luni Emdad, Swadesh K. Das, Devanand Sarkar, & Paul B. Fisher. (2017). The Enigma of miRNA Regulation in Cancer. Advances in cancer research. 135. 25–52. 37 indexed citations
15.
Pradhan, Anjan K., Rob DeSalle, Swadesh K. Das, et al.. (2017). New Insights Into Beclin-1: Evolution and Pan-Malignancy Inhibitor Activity. Advances in cancer research. 137. 77–114. 19 indexed citations
16.
Pradhan, Anjan K., Sarmistha Talukdar, Praveen Bhoopathi, et al.. (2016). mda-7/IL-24 Mediates Cancer Cell–Specific Death via Regulation of miR-221 and the Beclin-1 Axis. Cancer Research. 77(4). 949–959. 49 indexed citations
17.
Bhoopathi, Praveen, Nathaniel Lee, Anjan K. Pradhan, et al.. (2016). mda-7/IL-24 Induces Cell Death in Neuroblastoma through a Novel Mechanism Involving AIF and ATM. Cancer Research. 76(12). 3572–3582. 31 indexed citations
18.
Das, Swadesh K., Chunqing Guo, Anjan K. Pradhan, et al.. (2016). Knockout of MDA-9/Syntenin (SDCBP) expression in the microenvironment dampens tumor-supporting inflammation and inhibits melanoma metastasis. Oncotarget. 7(30). 46848–46861. 24 indexed citations
19.
Bharti, Rashmi, Goutam Dey, Indranil Banerjee, et al.. (2016). Somatostatin receptor targeted liposomes with Diacerein inhibit IL-6 for breast cancer therapy. Cancer Letters. 388. 292–302. 66 indexed citations
20.
Sarkar, Siddik, Anjan K. Pradhan, Swadesh K. Das, et al.. (2015). Novel therapy of prostate cancer employing a combination of viral-based immunotherapy and a small molecule BH3 mimetic. OncoImmunology. 5(3). e1078059–e1078059. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masayo Hosokawa Breakdown of academic impact, for papers by Hua Wu Breakdown of academic impact, for papers by Lucia Cappabianca Breakdown of academic impact, for papers by Taiji Yamazoe Breakdown of academic impact, for papers by Chan Choi Breakdown of academic impact, for papers by Charlotte E. Edling Breakdown of academic impact, for papers by Chun-Hau Chen Breakdown of academic impact, for papers by Jin Cen Breakdown of academic impact, for papers by Claudio Raimondi Breakdown of academic impact, for papers by Sean Garrison
Rankless by CCL
2026